VeriMomginkgo biloba leaf powder hamilelikte güvenli mi?
No harmonised CLP reproductive classification for Ginkgo biloba leaf (ECHA Annex VI). No SCCS or CIR safety assessment identifying reproductive hazards for topical use; available animal reproductive signals are from high‑dose oral exposures to extracts (PubMed) and do not establish a topical reproductive hazard. Dermal absorption from a cosmetic powder formulation is expected to be negligible, so systemic exposure in pregnancy from topical use is minimal (ECHA registration dossiers/PubChem for composition; PubMed for oral studies).
Pregnancy-safe products containing ginkgo biloba leaf powder
Related ingredients
Frequently asked questions
- ginkgo biloba leaf powder hamilelikte güvenli mi?
- No harmonised CLP reproductive classification for Ginkgo biloba leaf (ECHA Annex VI). No SCCS or CIR safety assessment identifying reproductive hazards for topical use; available animal reproductive signals are from high‑dose oral exposures to extracts (PubMed) and do not establish a topical reproductive hazard. Dermal absorption from a cosmetic powder formulation is expected to be negligible, so systemic exposure in pregnancy from topical use is minimal (ECHA registration dossiers/PubChem for composition; PubMed for oral studies).
- ginkgo biloba leaf powder emzirirken güvenli mi?
- No harmonised classification or authoritative cosmetic‑safety body (CIR/SCCS) conclusion indicating risk to lactation or breastfed infants from topical use. Systemic transfer via breastmilk is unlikely from low dermal exposure to a topical powder; oral high‑dose animal data do not translate to typical cosmetic use (PubMed, ECHA/CosIng).
- ginkgo biloba leaf powder bebek cildi için güvenli mi?
- Hazard and mechanism: no authoritative evidence of reproductive/developmental toxicity relevant to infant topical exposure (h=0, m=0). Exposure: increased by +1 for baby skin (e=1) because infants have an immature barrier and higher surface‑area‑to‑weight—if the ingredient has any measurable dermal absorption, infant exposure is higher than adult. There are no infant‑specific safety studies for topical Ginkgo biloba leaf powder in cosmetic products to demonstrate otherwise (PubMed/CosIng/ECHA).
- VeriMom ginkgo biloba leaf powder nasıl puanlıyor?
- VeriMom ginkgo biloba leaf powder'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte ginkgo biloba leaf powder yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.